Neoadjuvant immune checkpoint inhibitors in resectable non-small-cell lung cancer: a systematic review-Reference-Cited by-同舟云学术

Neoadjuvant immune checkpoint inhibitors in resectable non-small-cell lung cancer: a systematic review

Published:2021-10 Issue:5 Volume:6 Page:100244
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Ulas E.B.,Dickhoff C.,Schneiders F.L.,Senan S.,Bahce I.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference43 articles.

1. The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer;Goldstraw;J Thorac Oncol,2016

2. Prognostic and predictive biomarkers in early stage non-small cell lung cancer: tumor based approaches including gene signatures;Carnio;Transl Lung Cancer Res,2013

3. Recurrence after surgery in patients with NSCLC;Uramoto;Transl Lung Cancer Res,2014

4. Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data;Lancet,2014

5. Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC);Menzies;Nat Med,2021

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Die neoadjuvante Immunchemotherapie des nichtkleinzelligen Lungenkarzinoms: Was Thoraxchirurginnen und -chirurgen wissen müssen;Zeitschrift für Herz-,Thorax- und Gefäßchirurgie;2024-07-10

2. Video-Assisted Thoracoscopic Surgery Versus Thoracotomy Following Neoadjuvant Immunochemotherapy in Resectable Stage III Non-Small Cell Lung Cancer Among Chinese Populations: A Multi-Center Retrospective Cohort Study;Clinical Lung Cancer;2024-07

3. Predictive model based on multiple immunofluorescence quantitative analysis for pathological complete response to neoadjuvant immunochemotherapy in lung squamous cell carcinoma;Frontiers in Oncology;2024-06-03

4. T-cell subsets and cytokines are indicative of neoadjuvant chemoimmunotherapy responses in NSCLC;Cancer Immunology, Immunotherapy;2024-04-15

5. Mechanisms of resistance to targeted therapy and immunotherapy in non-small cell lung cancer: promising strategies to overcoming challenges;Frontiers in Immunology;2024-04-09